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Abstract 
Exacerbations are part of the natural history of chronic obstructive pulmonary disease and asthma. Severe exacerba‑
tions can cause acute respiratory failure, which may ultimately require mechanical ventilation. This review summarizes 
practical ventilator strategies for the management of patients with obstructive airway disease. Such strategies include 
non‑invasive mechanical ventilation to prevent intubation, invasive mechanical ventilation, from the time of intuba‑
tion to weaning, and strategies intended to prevent post‑extubation acute respiratory failure. The role of tracheos‑
tomy, the long‑term prognosis, and potential future adjunctive strategies are also discussed. Finally, the physiological 
background that underlies these strategies is detailed.
Keywords: Mechanical ventilation, Chronic obstructive pulmonary disease, Asthma, Intrisic positive end‑expiratory 
pressure (PEEP), Non‑invasive ventilation, Weaning
Introduction
Respiratory failure from acute exacerbations of chronic 
obstructive pulmonary disease (COPD) or severe asthma 
is characterized by acute worsening of respiratory symp-
toms associated with the development of severe airflow 
limitation, gas trapping, dynamic hyperinflation and 
intrinsic positive end-expiratory pressure (PEEPi). In the 
most severe cases, these exacerbations may cause acute 
respiratory failure, which may require mechanical ven-
tilation. This review focuses on strategies for ventilation 
and describes the physiological background that under-
lies them. Even though the pathogenesis and clinical 
course of asthma and COPD differ, ventilator support 
management of the two conditions is similar in various 
respects.
Acute respiratory failure in COPD and asthma: the 
magnitude of the problem
COPD exacerbations are common and have impor-
tant clinical consequences, including an acute decline 
in quality of life, temporary or permanent reduction in 
lung function and exercise capacity, hospitalization, and 
increased mortality. They also have a major economic 
impact. According to cohort studies that enrolled unse-
lected critically ill patients receiving mechanical ventila-
tion (invasive or non-invasive) for more than 12 h [1], the 
proportion of patients managed for COPD exacerbation 
decreased from 10% in 1998 to 7% in 2016 (Fig. 1). This 
trend paralleled an increased rate of non-invasive ven-
tilation (NIV) use as first ventilatory support following 
intensive care unit (ICU) admission (from 16% in 1998 to 
51% in 2017). Simultaneously, overall mortality decreased 
(Fig. 1).
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Severe asthma exacerbation causing respiratory fail-
ure may lead to major mechanical ventilation-associated 
complications (e.g., barotrauma, cardiovascular collapse, 
atelectasis, and pneumonia) that can impact on morbid-
ity and mortality. Severe asthma exacerbation accounts 
for approximately 1% of mechanically ventilated patients 
admitted to the ICU [1]. NIV use in these patients 
increased from 3% in 1998 to 34% in 2016 [2].
Respiratory system mechanics and gas exchange
In terms of respiratory system mechanics, asthma 
and COPD are characterized by the development of 
dynamic hyperinflation, defined as increased relaxa-
tion volume of the respiratory system at the end of a 
tidal expiration. In healthy subjects, the end-expiratory 
alveolar and airway pressures are zero relative to the 
atmosphere, and pleural pressure is negative. In the 
presence of dynamic hyperinflation, the alveolar pres-
sure remains positive throughout expiration, leading to 
the development of auto-positive end-expiratory pres-
sure (auto-PEEP), also termed intrinsic PEEP or PEEPi 
[3] (Fig. 2).
In COPD, PEEPi is primarily caused by expiratory 
flow limitation, a complex phenomenon that is due to 
reduced lung recoil pressure (emphysema) leading to 
small airway collapse that increases airway resistance 
(see [4] for an extensive description). It is exacerbated 
by shortened expiratory time, due to increased respira-
tory rate, and increased tidal volume, the latter being, in 
general, a consequence of an augmentation of respira-
tory drive (and therefore a higher volume to exhale) [5]. 
The consequences of dynamic hyperinflation depend on 
whether patients are passively ventilated or triggering 
their ventilator. In passively ventilated patients, dynamic 
hyperinflation increases delivered mechanical power [6] 
with its associated risk of barotrauma and hemodynamic 
compromise [7]. In patients triggering their ventilator, 
initiation of inspiratory flow requires inspiratory force 
to overcome PEEPi [8], which translates into increased 
inspiratory effort during the triggering phase. Ultimately, 
this increased effort may fail to trigger the ventilator, 
leading to ineffective triggering, one of the most frequent 
dyssynchronies [5]. In terms of gas exchange, patients 
with COPD have complex patterns of V/Q distributions: 
low V/Q regions that remain perfused, high V/Q regions, 
and mixed patterns. COPD patients often exhibit small 
amounts of shunt (typically less than 10% of cardiac out-
put) [9].
Severe asthma exacerbation is characterized by a 
major increase in airway resistance due to bronchos-
pasm, airway inflammation, and mucus. Expiratory flow 
is dramatically reduced with resultant major dynamic 
hyperinflation [10]. This leads to an increased risk of 
barotrauma and hemodynamic compromise. Hypox-
emia in asthma is characterized by the presence of low 
V/Q units; hypoxemia is usually attenuated by compen-
satory redistribution of blood flow mediated by hypoxic 
vasoconstriction and changes in cardiac output [9, 11]. It 
has been described that in asthma patients, hypercapnia 
is mainly due to increased dead space ventilation caused 
by alveolar overdistension [11, 12]. However, this mecha-
nism has not been proved [9].
Heart–lung interactions in the mechanically 
ventilated COPD patient
The pathophysiological changes in the pulmonary system 
may have adverse effects on cardiac function.
COPD is associated with pulmonary hypertension, 
increased pulmonary vascular resistance, right ventri-
cle dilatation, and right ventricle hypertrophy. Both left 
ventricle systolic and left ventricle diastolic functions are 
often impaired in COPD patients. Among 148 patients 
admitted to the ICU for severe COPD exacerbation, 31% 
had an exacerbation that was definitely associated with 
left-heart dysfunction [13]. These cardiac alterations are 
caused by dynamic hyperinflation and the large swings 
in negative intrathoracic pressure developed by the res-
piratory muscles to overcome the inspiratory elastic 
threshold caused by PEEPi and increased airway resist-
ance. Dynamic hyperinflation is more detrimental to left 
ventricle hemodynamics than large swings in negative 
intrathoracic pressure [14]. Direct ventricular interac-
tion and significant septal flattening appear to be respon-
sible for reduced left ventricle end-diastolic volume and 
stroke volume [15]. Dynamic hyperinflation worsens 
the increase in right ventricular impedance (afterload 
effect), while large negative intrathoracic pressure swings 
increase the venous return to the right ventricle (preload 
effect). Both favor direct ventricular interaction with left-
ward shift of the septum.
Application of external PEEP up to values approaching 
PEEPi does not result in hemodynamic impairment in 
COPD [4]. Higher PEEP levels reduce cardiac index [16]. 
However, the effects of external PEEP on lung mechan-
ics and hemodynamics depend on many factors, such 
as airway characteristics, lung volumes, intravascular 
Take‑home message 
This review summarizes practical ventilator strategies to manage 
patients with asthma and chronic obstructive pulmonary disease 
(COPD). The causes, impact and management of dynamic hyperin‑
flation are discussed, as well as heart–lung interaction. We underline 
the importance of non‑invasive ventilation to prevent intubation. 
We provide key messages regarding ventilator settings in intubated 
patients. Future adjunctive strategies are discussed.
volume status, vasomotor tone, etc., making the individ-
ual patient’s response difficult to predict [17].
Finally, patients with COPD are at increased risk 
of difficult weaning, and are susceptible to develop-
ing weaning-induced pulmonary edema in particular 
[18]. Diuretics and nitroglycerin are efficient in treating 
weaning-induced pulmonary edema in selected COPD 
patients [19, 20].
In patients with severe asthma, similar heart–lung 
interactions are observed. Because of the presence of an 
extremely severe hyperinflation, they may develop severe 
hypotension [21].
Non‑invasive ventilation in COPD over the decades
Delivering mechanical ventilation without intubation in 
patients with  CO2 retention was attempted during the 
1960s [22], but without becoming widely accepted; intu-
bation with invasive mechanical ventilation remained the 
rule for patients admitted for respiratory failure.
In the late 1980s, several groups treated patients 
with chronic or acute-on-chronic hypercapnic respira-
tory failure with a face mask [23–26]. The success was 
largely due to combining physiological assessment of 
the mechanisms of respiratory failure (including respira-
tory muscle function [26]) with new technologies (pres-
sure support ventilation [27]). In the early 1990s several 
studies demonstrated the efficacy of positive pressure 
ventilation usually delivered with pressure support ven-
tilation and PEEP [28, 29]. It is remarkable that some of 
the best results were obtained without any PEEP [26], 
highlighting the importance of pressure delivered dur-
ing inspiration. Randomized clinical trials showed that 
the intubation rate was dramatically reduced, resulting 
in improved outcomes, with fewer complications related 
to invasive mechanical ventilation and improved hospital 
survival [30–32] (Fig. 3).
Implementing NIV into practice took more than a dec-
ade [33] but NIV became the benchmark for treating 
acute respiratory failure due to severe COPD exacerba-
tion, bringing about a steady decrease in mortality over 
time [33]. Concomitantly, the risk of mortality increased 
in patients transitioned from NIV to invasive mechani-
cal ventilation. However, it is of note that COPD patients 
who failed NIV and were subsequently intubated were 
not at higher risk of mortality than those intubated as 
a first-line respiratory support [30, 33]. Technological 
improvements continued, stimulated by the need for 
efficient techniques in the hospital and by the extensive 
use of home NIV, which required more comfortable and 
user-friendly equipment [34]. Automated management of 
leaks progressively became the rule and ICU ventilators 
eventually became as efficient as dedicated ventilators in 
compensating for leaks and reducing patient-ventilator 
dyssynchronies [35, 36].
NIV is sometimes proposed as a ceiling of ventila-
tor assistance care [37–39]. A multicenter French study 
showed that patients with “do-not-intubate” orders 
who were managed with NIV had good quality of life 
6  months after discharge; caregivers of patients treated 
with NIV had similar stress and anxiety levels to those 
of caregivers of patients with no limitation on therapy 
Fig. 1 Rates of acute chronic obstructive pulmonary disease (COPD) 
exacerbation and severe asthma exacerbation among patients 
mechanically ventilated for acute respiratory failure (panel A) and 
evolution of ICU mortality (panel B) and hospital mortality (panel C) 
over time in these two populations. *p < 0.001 compared to period 
1998
[39]. Because NIV relieves dyspnea [40], the technique 
has also been used to relieve dyspnea in dying patients 
receiving palliative care [41], although this approach has 
not gained widespread use.
In severe asthma exacerbation, retrospective studies 
have suggested that cautious use of NIV was associated 
with improved outcome [42]. However, no high-quality 
randomized controlled trial has highlighted benefits of 
NIV in severe asthma exacerbation, and the level of risk 
may be very high in cases of respiratory failure. As a con-
sequence, guidelines do not recommend NIV in severe 
asthma exacerbation [43, 44].
Management of invasive ventilation
Invasive ventilation is indicated in patients suffering a 
respiratory arrest, for instance, or who have failed NIV 
Fig. 2 Pressure–volume (P–V) relationship of the respiratory system when pressure is measured at the airway opening. In normal subjects, the 
end‑expiratory lung volume  (EELVNormal) is the relaxation volume of the respiratory system or functional residual capacity (FRC), where no inward or 
outward recoil pressure exists (the pressure of the respiratory system is 0 cmH2O relative to the atmosphere). To trigger the ventilator, the patient’s 
inspiratory muscles have to develop an inspiratory effort ≥ the trigger threshold set on the ventilator (2 cmH2O in the example). A tidal breath of 
500 ml delivered by the ventilator will increase the volume of the respiratory system to its end‑inspiratory lung volume  (EILVNormal). The normal elas‑
tic work of breathing  (Wel,n) represented by the triangular area is not excessive. In hyperinflated COPD or asthma patients, the end‑expiratory lung 
volume  (EELVHyperinfl) is greater than the respiratory system relaxation volume, increasing ΔFRC (Δ denoting the increase in volume from the normal 
FRC); at this increased volume, an inward recoil pressure exists (the pressure of the respiratory system is 7 cmH2O relative to the atmosphere). This 
pressure is called the intrinsic positive end‑expiratory pressure (PEEPi). (This pressure is usually measured by the end‑expiratory occlusion method 
with the patient relaxed). To trigger the ventilator, the patient’s inspiratory muscles first have to develop an inspiratory effort to overcome the 
positive inward recoil of the respiratory system present at the end of expiration (7 cmH2O, PEEPi) and then the trigger threshold set on the ventila‑
tor (2 cmH2O in the example). The pressure required to effectively trigger the ventilator (Peffect,trigger = 7 + 2 = 9 cmH2O in the example). If they fail 
to generate this amount (9 cmH2O), an ineffective triggering effort ensues, which does not trigger the ventilator. A similar tidal breath of 500 ml 
delivered by the ventilator will increase the volume of the respiratory system to its new end‑inspiratory lung volume  (EILVhyperinfl), where there is risk 
of overdistension (stress and strain of the lung) with its potentially injurious sequalae (this is the plateau pressure if measured by the end‑inspiratory 
occlusion method with the patient relaxed). The elastic work of breathing is mainly attributed to PEEPi (square shaded area,  WPEEPi) and is greatly 
increased leading to increased delivered mechanical power
for any reason, including persistent clinical signs of 
increased work of breathing. As previously explained (see 
above section “Respiratory system mechanics and gas 
exchange”), acute exacerbations of COPD are character-
ized by dynamic hyperinflation leading to development 
of PEEPi. The presence of dynamic hyperinflation and 
PEEPi should be considered if expiratory flow does not 
cease at end-expiration (Fig. 4). With controlled mechan-
ical ventilation, total PEEP is measured during end-
expiratory occlusion. The reference standard technique 
for quantifying dynamic hyperinflation is measurement 
of end-inspiratory lung volume [45]. As this is cumber-
some in clinical practice, end-inspiratory plateau pres-
sure (Pplat) during controlled mechanical ventilation is a 
reasonable, albeit less sensitive, surrogate for monitoring 
hyperinflation [45]. Pplat is measured with end-inspir-
atory occlusion for ± 3  s. Peak pressure is not a reliable 
measure for hyperinflation.
It is important to stress that in the early phase of 
mechanical ventilation, the primary goal in these patients 
is not to normalize blood gases, but to prevent compli-
cations due to hyperinflation while maintaining a pH of 
around 7.25–7.30 [46].
Many ventilator modes are used in intubated patients 
with COPD; however, it is not known whether one is 
superior to another. A common ventilator mode is vol-
ume assist-control ventilation. With volume assist-
control ventilation, the inspiratory flow waveform can 
be set in the square pattern to facilitate monitoring of 
mechanics. To limit hyperinflation, minute ventilation 
is minimized, and sufficient time is allowed for expira-
tion [45]. As a reasonable starting point, use of a moder-
ate tidal volume, of around 6–8 ml/Kg, and a respiratory 
rate of 12/min, with constant inspiratory flow delivered 
at 60–90 l/min, has been proposed [47]. It has been pro-
posed to keep the inspiration-to-expiration ratio low, 
e.g., 1:4. If, with these ventilator settings, Pplat is not 
too high (e.g., < 28  cmH2O), the respiratory rate can 
be increased to improve gas exchange. If Pplat is high 
(e.g. > 28  cmH2O), minute ventilation could be reduced 
by limiting tidal volume and/or respiratory rate in 
patients with PEEPi. Increasing expiration time at similar 
minute ventilation (e.g. by increasing inspiratory airflow 
thus decreasing inspiratory time with constant respira-
tory rate and tidal volume) has a much smaller effect on 
hyperinflation [45].
Selecting appropriate PEEP in acute COPD exacerba-
tion may be complex and depends on whether or not the 
patient triggers her/his ventilator. In general, at the early 
phase of intubation, patients do not trigger their ven-
tilator. In theory, zero PEEP would be optimal in these 
COPD patients with “pure” high airway resistance, as 
PEEP reduces expiratory driving pressure and is therefore 
expected to increase hyperinflation. However, the physi-
ology appears more complex, with three possible effects 
of PEEP on hyperinflation [48]: (1) in patients with pure 
expiratory flow limitation, there is no change in hyperin-
flation (assessed by Pplat and by changes in end-expira-
tory lung volume) during progressive increase in PEEP 
until a threshold is reached; (2) any increase in PEEP 
increases Pplat and end-expiratory lung volume, and (3) 
a “paradoxical response” occurs, whereby increases in 
PEEP decrease Pplat and end-expiratory lung volume. A 
paradoxical response may be expected in patients with 
expiratory flow limitation and highly heterogeneous 
lungs [7, 49]. At the bedside, the effect of PEEP on hyper-
inflation is unpredictable [48], and it is therefore advised 
to measure Pplat while cautiously titrating PEEP. PEEP 
titration should be immediately stopped if Pplat increases 
[12].
In passively ventilated patients with expiratory flow 
limitation, the addition of external PEEP does not change 
either the degree of hyperinflation or the total PEEP until 
it approximates 80% of the original PEEPi. As soon as the 
patient is able to trigger the ventilator, moderate exter-
nal PEEP is added to counterbalance PEEPi and hence 
to reduce the effort needed to trigger the ventilator and 
improve patient-ventilator interaction [50]. It is of note 
that patients with COPD are susceptible to ventilator-
induced hyperinflation and dyssynchronies such as inef-
fective triggering (also called ineffective efforts or wasted 
efforts, Fig.  5) [50]. Because PEEPi increases the effort 
required to trigger the ventilator, a weak respiratory effort 
may fail to trigger it [51]. Ineffective triggering is associ-
ated with a less sensitive inspiratory trigger, a higher level 
of pressure support, a higher tidal volume, and a higher 
pH [50]. In patients with a high prevalence of ineffective 
triggering, markedly reducing pressure support or inspir-
atory duration to reach a tidal volume of about 6 ml/Kg 
predicted body weight was found to eliminate ineffective 
triggering in two-thirds of patients [52]. When pressure 
support is used, the pressure support level should not be 
set too high, to limit tidal volume (to around 6–8 ml/Kg) 
and subsequent dynamic hyperinflation [52]. Shortening 
insufflation time by decreasing the level of the expiratory 
trigger (also called cycling-off) may also help to reduce 
dynamic hyperinflation [52].
In severe asthma exacerbation, invasive mechani-
cal ventilation is associated with an increased risk of 
complications and significant mortality [53]. Post-
intubation hypotension is common, due to major 
lung hyperinflation, hypovolemia and sedation. 
Therefore, the indication for intubation should be 
limited to patients in life-threatening conditions (res-
piratory arrest, bradypnea, altered consciousness, 
patients totally exhausted and/or with severe and 
worsening hypercapnia or major respiratory distress 
despite adequate medical treatment). Because of the 
major increase in expiratory resistance due to airway 
obstruction related to edema and bronchospasm, pul-
monary hyperinflation might be extremely high in 
asthmatics. The key ventilatory strategy is to mini-
mize hyperinflation, which is best achieved by reduc-
ing minute ventilation and lengthening expiratory time 
(low tidal volume, low respiratory rate [45] and high 
inspiratory airflow rate with the objective of targeting 
an inspiratory-to-expiratory time of 1:4 to 1:6). A low 
level of external PEEP (≤ 5  cmH2O) is recommended 
by some authors, although this strategy is disputed 
[54]. The degree of hyperinflation must be closely 
monitored (using end-inspiratory and end-expiratory 
holds) with the aim of limiting Pplat and obtaining the 
lowest possible total PEEP [53]. As in COPD, using a 
volumetric mode with square wave airflow delivery 
allows easier monitoring. As an effect of major reduc-
tion of minute ventilation,  PaCO2 might increase 
dramatically [46]; reduction of  PaCO2 is very much a 
secondary goal.
Weaning from mechanical ventilation
Readiness to wean needs to be screened on a daily basis 
according to guidelines (Fig.  3) [55]. In ready-to-wean 
patients, a spontaneous breathing trial is performed, 
with either T-tube or pressure support ventilation [56]. 
In patients who tolerate the spontaneous breathing 
trial, it is possible to proceed with extubation.
In COPD patients, prophylactic post-extubation NIV 
and use of high-flow nasal cannula both decrease the 
occurrence of acute respiratory failure and subsequent 
reintubation (Fig. 3) [57, 58]. The addition of NIV ses-
sions to high-flow nasal cannula use seems to be more 
efficient for preventing reintubation than use of high-
flow nasal cannula alone [59]. Finally, NIV can also 
hasten weaning in COPD patients who repeatedly fail 
spontaneous breathing trials [60].
In a series of 208 patients intubated for hypercapnic 
respiratory failure, 4.4% required ventilation via tra-
cheostomy at discharge [61]. The decision to opt for 
tracheostomy is made on the basis of considerations 
about, for example, the risks of the procedure versus 
its anticipated but unproven benefits [62]. In the diffi-
cult-to-wean patient, possible tracheostomy should be 
Fig. 3 Therapeutic options at the different stages of patient management. NIV non‑invasive ventilation, PEEP positive end‑expiratory pressure, NAVA 
neurally adjusted ventilator assist; PAV proportional assist ventilation
the subject of a multidisciplinary discussion [63]. The 
patient and his or her family must be informed that tra-
cheostomy does not alter the prognosis of the causal 
disease. Although tracheostomy can improve comfort 
[64], it may unduly prolong suffering associated with 
the underlying illness. In a context of chronic respira-
tory failure, these ethical considerations must be care-
fully thought through and discussed with the patient 
and his or her family before performing a tracheostomy.
Long‑term outcome
In a small series of patients with COPD requiring pro-
longed mechanical ventilation (> 21 days), 2-year survival 
was 40% (68% in patients weaned from the ventilator 
and 22% in those not weaned) [65]. In another cohort of 
patients (59% with COPD) requiring prolonged ventila-
tion at a weaning center, 1-year survival was 49% [66].
A prospective longitudinal study investigated the effect 
of prolonged mechanical ventilation on survival and qual-
ity of life in 315 patients with various causes of respira-
tory failure (95 had COPD as primary or secondary cause 
of respiratory failure) [67, 68]. Among the patients who 
survived to discharge from the weaning facility, 54% were 
detached from the ventilator and 30% were still attached 
to the ventilator at the time of discharge from the facil-
ity. The 1-year survival was 63% for ventilator-detached 
patients and 22% for the ventilator-attached patients. 
Survival was not influenced by the underlying cause of 
respiratory failure, including COPD [68]. By 12 months, 
the SF36 physical-summary score and mental-summary 
score returned to pre-illness values, and 85% of patients 
indicated their willingness to undergo ventilation again 
[68, 69].
Do particular features emerge in middle‑income 
countries?
The burden of COPD and asthma is disproportionally 
high in low-resource countries due to high indoor/out-
door air pollution (smoking, exposure to coal indoors 
and to dust in the workplace) [70, 71]. The death toll from 
chronic respiratory diseases is a real challenge to the 
public health systems in developing countries, since the 
highest risk of dying from non-communicable disease is 
observed in low- and middle-income countries [72].
In addition, in most low- and middle-income countries, 
ICUs are scarce, and resources are limited. The avail-
ability of invasive mechanical ventilation, in particular, is 
limited, and its use is associated with a high risk of mor-
tality, especially from ventilator-associated pneumonia 
[73–75]. As in high-income countries, NIV should be 
preferred to invasive ventilation, particularly in cases of 
COPD exacerbation. A recent meta-analysis summariz-
ing experience of NIV in these countries reported a mod-
erate risk of mortality in adults (16%), and a mean NIV 
failure rate of 28.5% in adults in this population [73]. For 
COPD exacerbation, the use of NIV as the primary venti-
latory mode increased from a rate of 29% in 2000 to 97% 
in 2012 [76]. This change was associated with gradual 
falls in the rates of NIV failure (learning curve), ventila-
tor-associated pneumonia, and concurrent use of antibi-
otics [76]. These data suggest that guidelines regarding 
the preferential use of NIV therapy are not specific to 
high-income countries and should also be applied to low- 
and middle-income countries.
New avenues of research
NIV has well-known drawbacks. Patient tolerance may 
be poor due to patient discomfort, dyspnea, skin dam-




Fig. 4 Schematic representation of pressure and flow recordings in two mechanically ventilated patients. In a healthy subject (panel A) expiratory 
flow ceases at end‑expiration, ruling out dynamic hyperinflation. In a COPD patient (panel B), expiratory flow does not cease at end‑expiration, 
which suggests dynamic hyperinflation and intrinsic positive end‑expiratory pressure (PEEPi)
is important to the success of this technique. High-flow 
nasal cannula may be an alternative method [77, 78]. 
In a recent study conducted in 12 hypercapnic COPD 
patients with mild to moderate exacerbation who had ini-
tially required NIV, applying high-flow nasal cannula at 
30  l/min for a short duration reduced inspiratory effort, 
and resulted in an effect similar to that of NIV delivered 
at moderate levels of pressure support [78]. In addition, 
high-flow nasal cannula is a more comfortable technique 
than NIV [79, 80].
Given the fact that approximately 15% of COPD 
patients fail NIV, attempts have been made to improve 
the efficacy of NIV. These attempts include inhalation 
of helium and oxygen gas mixtures, which requires a 
complex setting and a specific ventilator. Because of its 
low density compared with air, helium/oxygen markedly 
enhanced the ability of NIV to reduce patients’ effort and 
to improve gas exchange [81]. However, despite some 
improvement of several physiological variables, rand-
omized controlled trials did not show a clinical benefit 
(i.e., reduction in intubation rate or mortality) [82, 83] 
with the use of helium/oxygen mixture. The relatively low 
rate of intubation already achieved with NIV alone may 
explain the lack of benefit with helium/oxygen mixture.
More recently, extracorporeal  CO2 removal has been 
considered as a possible adjunct to NIV to avoid intuba-
tion in patients not responding to NIV [84]. Combining 
NIV with direct removal of  CO2 is postulated to improve 
Fig. 5 Tracings (from top to bottom) of airway pressure (Paw), airflow (Flow), esophageal pressure (Pes), gastric pressure (Pga), transdiaphragmatic 
pressure (Pdi) and tidal volume (VOLUME) in a chronic obstructive pulmonary disease (COPD) patient exhibiting significant respiratory muscle effort 
during an episode of acute respiratory failure—due to a congestive heart failure during weaning—while mechanically ventilated with positive 
end‑expiratory pressure (PEEP) of 6 cmH2O and a pressure support level of 8 cmH2O. This patient shows dynamic hyperinflation (average corrected 
intrinsic PEEPi 8 cmH2O), and major recruitment of expiratory muscles (as reflected by the raising Pga during expiration). Of note, the presence of 
numerous ineffective triggering efforts indicated by the arrows (ventilator respiratory rate is about 18 breaths/min and the patient’s respiratory rate 
is about 28 breaths/min). From Cabello B, Mancebo J (2003) Withdrawal from mechanical ventilation in patients with COPD: the issue of congestive 
heart failure. In: Vincent J‑L (ed) Yearbook of intensive care and emergency medicine. Springer‑Verlag, Berlin, Heidelberg, pp 295–301
alveolar ventilation and reduce the respiratory muscle 
workload. Extracorporeal  CO2 removal can also be used 
to accelerate weaning from endotracheal intubation as it 
may prevent ineffective shallow-breathing patterns and 
reduce inspiratory work by maintaining stable  PaCO2 
levels during unsupported breathing [85]. Although these 
devices eliminate carbon dioxide efficiently, experimen-
tal evidence of their effectiveness in patients with COPD 
is limited. Demonstrating benefits in COPD will be chal-
lenging because of complications associated with extra-
corporeal  CO2 removal [86].
Another strategy to improve the prognosis of COPD 
patients is to optimize patient-ventilator interaction. 
Contrary to what occurs with pressure support ventila-
tion, proportional modes of ventilation assist the patient 
by delivering a level of assistance that is proportional 
to his/her inspiratory effort [87]. There are two propor-
tional modes: neurally adjusted ventilatory assist (NAVA) 
and proportional assist ventilation (PAV). NAVA is a 
mode that triggers, cycles and regulates inspiratory air-
flow based on the diaphragmatic electromyography sig-
nal. There is no influence of PEEPi during the ventilator 
assistance, since it starts with the patient’s own breathing 
effort; furthermore, thanks to better patient-ventilator 
interaction, there should be no effect of leaks during NIV 
[88–90]. Several studies have shown that NAVA improves 
patient-ventilator interaction, diaphragm efficiency and 
patient comfort, as compared with pressure support 
ventilation [91]. However, no clear clinical advantage of 
NAVA over PAV has been demonstrated, although NAVA 
might be beneficial in difficult weaning [91, 92]. With 
PAV, the inspiratory assist is proportional to the activity 
of the inspiratory muscles, which is calculated from the 
measured flow and volumes using the equation of motion 
of the respiratory system [87]. PAV protects against high 
tidal volume and subsequent dynamic hyperinflation 
[93]. The use of PAV is associated with a shorter weaning 
time compared with pressure support ventilation [94].
A striking feature of patients treated with NIV or 
invasive ventilation is the high rate of ICU or hospital 
readmissions [95]. At least 50% of patients surviving an 
ICU stay will be readmitted within a year, and this per-
centage can reach 80% in some studies. Two factors may 
explain this high rate. First, patients may continue to 
need ventilation at home [96], but this practice has not 
been developed widely. Recent trials of home NIV for 
patients surviving an ICU admission suggest important 
potential benefits [34]. Second, many of these patients 
have untreated or undiagnosed comorbidities, especially 
sleep-related breathing disorders and cardiac dysfunction 
[97, 98]. New approaches are needed to reduce this high 
readmission rate.
Ultrasound can be used to evaluate respiratory mus-
cle function and help manage mechanically ventilated 
patients [99], as it can give a gross estimation of dia-
phragm function [100]. In patients presenting with 
acute exacerbations of COPD in the emergency room, 
diaphragm dysfunction was associated with NIV failure 
[101], but these results have not been prospectively vali-
dated. Diaphragm dysfunction is also associated with a 
higher risk of weaning failure [102, 103]. Ultrasound can 
also be used to examine extra-diaphragmatic inspiratory 
muscle function, focusing on the intercostal parasternal 
muscle for example [104] (Fig.  6). Increased parasternal 
intercostal activity is associated with diaphragm dys-
function and weaning failure [104]. Ultrasound can also 
be applied to image the lungs in COPD, and may be use-
ful in differentiating causes of acute dyspnea in these 
patients [105]. It can also help in identifying pneumo-
thorax, pleural effusion, consolidation or cardiogenic 
edema. Whether such ultrasound imaging of the respira-
tory muscles improves patient outcomes remains to be 
determined. In addition, training and skills are required 
to ensure safe and worthwhile implementation.
Summary
Mechanical ventilation is the cornerstone of the man-
agement of COPD and asthma patients presenting with 
life-threatening respiratory failure. Although NIV pre-
vents the majority of patients with COPD exacerbation 
from subsequently needing invasive ventilation, future 
efforts should focus on improving the efficacy of NIV and 
on evaluation of the high-flow nasal cannula technique. 
Invasive mechanical ventilation is reserved for patients 
who fail NIV and are subsequently intubated. The major 
goal during invasive mechanical ventilation is to limit 
hyperinflation; this is achieved through reduced minute 
ventilation, low tidal volumes and prolonged expiratory 
time. Normalization of blood gas is a secondary thera-
peutic goal. A low level of external PEEP may be applied 
to patients triggering their ventilator. Mechanical ventila-
tion of asthma patients follows the same rules except that 
the use of NIV is not presently recommended despite 
promising recent data. Weaning should be performed as 
expeditiously as possible with a daily screening test fol-
lowed by a trial of spontaneous breathing. In selected 
patients, prophylactic post-extubation NIV prevents 
post-extubation acute respiratory failure and subsequent 
reintubation. High-flow nasal cannula seems as efficient 
as NIV to prevent reintubation and the combination of 
NIV and high-flow nasal cannula may be even more effi-
cient. Finally, tracheostomy should be the subject of a 
multidisciplinary discussion.
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